FDA PRIA Reference Data
Summary
The FDA has published reference data related to the Prescription Drug User Fee Act (PRIA) for May 2024. This notice includes national employment data relevant to PRIA submissions. It serves as an informational update for regulated entities.
What changed
The Food and Drug Administration (FDA) has released PRIA Reference 5, dated May 2024, which includes national employment data. This data is likely intended to support or inform submissions made under the Prescription Drug User Fee Act (PRIA).
This document appears to be an informational notice providing reference data for drug manufacturers and medical device makers. No specific actions are mandated by this notice, and it does not appear to introduce new compliance obligations or deadlines. Regulated entities may find this data useful for their PRIA-related activities.
Source document (simplified)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.